Items where authors include "Freeman, A."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Giganti, F., Ng, A., Asif, A. et al. (91 more authors) (2023) Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology, 309 (1). e231130. ISSN 0033-8419
Scott, E. orcid.org/0000-0002-5358-5132, Archer Goode, E., Garnham, R. et al. (39 more authors) (2023) ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. The Journal of Pathology, 261 (1). pp. 71-84. ISSN 0022-3417
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Asif, A., Nathan, A., Ng, A. et al. (47 more authors) (2023) Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open, 13 (4). e070280. ISSN 2044-6055
Scott, E., Hodgson, K., Calle, B. orcid.org/0000-0002-9893-9803 et al. (56 more authors) (2023) Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. Oncogene, 42. pp. 926-937. ISSN 0950-9232
Zeng, C., Guo, X., Long, J. et al. (234 more authors) (2016) Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research, 18 (1). 64. ISSN 1465-542X
Andrews, R., Freeman, A., Hou, D. et al. (3 more authors) (2007) The effectiveness of information and communication technology on the learning of written English for 5- to 16-year-olds. British Journal of Educational Technology, 38 (2). pp. 325-336. ISSN 0007-1013
Andrews, R., Torgerson, C., Beverton, S. et al. (5 more authors) (2006) The effect of grammar teaching on writing development. British Educational Research Journal, 32 (1). pp. 39-55. ISSN 0141-1926
Other
Beucke, D., Brandt, S., Chiarelli, A. et al. (11 more authors) (2025) Understanding the current landscape of alternative publishing platforms. Octopus.
Beucke, D., Brandt, S., Chiarelli, A. et al. (11 more authors) (2025) What approaches do research funders have towards alternative publishing platforms, and how important are they in the context of funders’ wider scholarly communication strategies? Octopus.